These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8583370)

  • 21. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of selective opioid antagonists on butorphanol-induced feeding.
    Levine AS; Grace M; Portoghese PS; Billington CJ
    Brain Res; 1994 Feb; 637(1-2):242-8. PubMed ID: 8180802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.
    Hirota K; Okawa H; Appadu BL; Grandy DK; Devi LA; Lambert DG
    Anesthesiology; 1999 Jan; 90(1):174-82. PubMed ID: 9915326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of mu-opioid receptors and alpha-adrenoceptors in the immunomodulatory effects of dihydroetorphine.
    Wu WR; Zheng JW; Li FY; Li Y; Zhang KR; Bai HQ
    Eur J Pharmacol; 1998 Jul; 353(1):79-85. PubMed ID: 9721043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between laudanosine, GABA, and opioid subtype receptors: implication for laudanosine seizure activity.
    Katz Y; Weizman A; Pick CG; Pasternak GW; Liu L; Fonia O; Gavish M
    Brain Res; 1994 May; 646(2):235-41. PubMed ID: 8069669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal delta 2-, but not delta 1-, mu-, or kappa-opioid receptors are involved in the tail-flick inhibition induced by beta-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat.
    Tseng LF; Tsai JH; Collins KA; Portoghese PS
    Eur J Pharmacol; 1995 Apr; 277(2-3):251-6. PubMed ID: 7493616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of novel diazatricyclodecanes (DTDs). Effects of structural variation at the C3' allyl end and at the phenyl ring of the cinnamyl chain on mu-receptor affinity and opioid antinociception.
    Pinna GA; Cignarella G; Ruiu S; Loriga G; Murineddu G; Villa S; Grella GE; Cossu G; Fratta W
    Bioorg Med Chem; 2003 Sep; 11(18):4015-26. PubMed ID: 12927864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinociceptive role of oxytocin in the nucleus raphe magnus of rats, an involvement of mu-opioid receptor.
    Wang JW; Lundeberg T; Yu LC
    Regul Pept; 2003 Oct; 115(3):153-9. PubMed ID: 14556956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supraspinal administration of opioids with selectivity for mu-, delta- and kappa-opioid receptors produces analgesia in amphibians.
    Stevens CW; Rothe KS
    Eur J Pharmacol; 1997 Jul; 331(1):15-21. PubMed ID: 9274924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and structure--activity relationship of novel aminotetralin derivatives with high micro selective opioid affinity.
    Roy C; Li T; Krasik P; Gilbert MJ; Pelletier C; Gagnon D; Robert E; Ducharme J; Storer R; Lavallée JF
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3141-3. PubMed ID: 12372519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
    Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
    J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury.
    Zhang J; Haddad GG; Xia Y
    Brain Res; 2000 Dec; 885(2):143-53. PubMed ID: 11102568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.